Target intelligence / Profile preview

Guanylate cyclase-activating protein 1 (GCAP1)

Target
GCAP1
Molecular classification
Neuronal calcium sensor protein, EF-hand domain–containing protein, Enzyme regulator, Calcium-binding protein, Phototransduction cascade component
01

Overview

Guanylate cyclase-activating protein 1 (GCAP1) is a neuronal calcium sensor protein primarily expressed in rod and cone photoreceptors of the retina. It detects changes in intracellular Ca²⁺ concentration and acts as a molecular switch: at low Ca²⁺ (light-adapted state), GCAP1 binds Mg²⁺ and activates retinal guanylate cyclase (RetGC), promoting the synthesis of cyclic GMP necessary for photoresponse recovery; at high Ca²⁺ (dark state), GCAP1 inhibits RetGC to maintain cGMP homeostasis. This regulation is crucial for visual processing and photoreceptor viability. GCAP1 contains multiple EF-hand domains for Ca²⁺/Mg²⁺ binding and is myristoylated at its N-terminus. Pathogenic mutations in GUCA1A can disrupt the calcium-sensing or regulatory function, resulting in inherited forms of retinal degeneration, especially various cone and cone-rod dystrophies, due to altered cGMP and Ca²⁺ homeostasis in photoreceptors[1][2][3][4][5].

Other names
GUCA1AC6orf131GCAPGUCA1COD3dJ139D8.6CORD14GCAP-IGCAP-1Guanylate cyclase activator 1Acone dystrophy 3photoreceptor 1guanylin 1guanylyl cyclase-activating protein 1guanylate cyclase-activating protein, retina
02

Mechanism of action

Allosteric modulation of retinal guanylate cyclase (RetGC) activity (activation at low Ca²⁺/Mg²⁺-bound, inhibition at high Ca²⁺) Mutant forms can constitutively activate RetGC leading to photoreceptor pathology

03

Biological functions

Regulation of guanylate cyclase activitySensory signal transduction (phototransduction)Calcium/Magnesium ion sensingRecovery of retinal photoreceptors after photobleaching
04

Disease associations

Retinal degenerative diseases (Cone dystrophy 3, Cone-rod dystrophy 14, macular dystrophy)Photoreceptor degeneration
05

Safety considerations

Gain-of-function mutations can cause excessive cGMP synthesis and toxic Ca²⁺ influx, leading to photoreceptor degenerationDominant-negative effects in retinal diseases due to some types of mutations
06

Biomarkers

Mutations in GUCA1A as genetic biomarkers for cone/cone-rod/macular dystrophies

Beyond the preview

Go deeper on Guanylate cyclase-activating protein 1 (GCAP1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Guanylate cyclase-activating protein 1 (GCAP1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call